ArticleJournal of the Endocrine Society2026
The Association Between Measures of Prepregnancy Insulin Resistance and Sensitivity with Subsequent Risk of Gestational Diabetes.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Little is known about the association between prepregnancy homeostasis model assessment of insulin resistance (HOMA-IR) and homeostasis model assessment of β-cell function (HOMA-β) levels and risk of gestational diabetes mellitus (GDM). Objective: To examine the association between prepregnancy levels of HOMA-IR and HOMA-β and risk of GDM and whether these associations vary by race and ethnicity. Research Design and Methods: We conducted a nested case-control study among women who had a serum sample from 1984 to 1996 used to measure glucose and insulin and a subsequent pregnancy from 1984 to 2009. GDM cases (n = 254) were matched with 2 randomly selected control subjects (n = 497) on serum collection date, age at collection, number of intervening pregnancies, and age at delivery. We used conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for GDM by HOMA-IR and HOMA- β, overall and stratified by race and ethnicity. Results: Increasing levels of HOMA-IR were associated with higher odds of GDM (adjusted OR for 1 SD increase: 1.31 [95% CI 1.12,1.54]) and tertile 3 compared to tertile 1 (3.04 [95% CI 1.81, 5.12]). Models stratified by race/ethnicity suggest this association was significant among Asian and non-Hispanic Black populations for tertile 3 (3.83 [95% CI 1.39, 10.57] and 2.18 [95% CI 1.03, 4.61], respectively). Among non-Hispanic Black individuals, a 1 SD increase in HOMA-IR also increased risk of GDM (OR: 1.59, 95% CI 1.17, 2.17). There was no significant association between HOMA-IR and GDM among non-Hispanic White or Hispanic individuals. There was no association between HOMA-β and GDM risk. Conclusion: Higher HOMA-IR levels before pregnancy were associated with an elevated risk of GDM.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.